Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26F18FX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $116,847
Award facts
- Contract value 100% obligated
- $116,847.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $116,847.34 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order is not set-aside and will be performed in Conshohocken, Pennsylvania, where the contractor is headquartered. Dupixent is a specialty pharmaceutical used to treat conditions including eczema, asthma, and chronic rhinosinusitis, reflecting the Defense Logistics Agency's need to supply advanced biologics to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards covering a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. The non-set-aside status and firm fixed pricing reflect the contractor's demonstrated capability to meet federal procurement requirements through open competition and support critical medical supply needs for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F18FX?
SPE2DR26F18FX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F18FX worth?
The government has obligated $116,847 on SPE2DR26F18FX.
Is contract SPE2DR26F18FX an order under another contract?
Yes. SPE2DR26F18FX is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18FX competed?
The extent of competition for SPE2DR26F18FX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award